File

CURO Group Holdings Corp. to Reduce Debt and Strengthen Financial Position Through Restructuring Support Agreement; Implements Prepackaged Restructuring Plan by Commencing Voluntary Chapter 11 Reorganization

Retrieved on: 
Monday, March 25, 2024
Banking, Fintech, Professional Services, Finance, Empyrean, RSA, Growth, Vinson & Elkins, Disclosure, Bankruptcy Code, DIP, LLP, Senior, United States bankruptcy court, Bankruptcy, Credit, Corporate action, OTC, File, Oaktree Capital Management, LP, Security (finance)

CURO also intends to file recognition proceedings in Canada under Part IV of the Companies’ Creditors Arrangement Act.

Key Points: 
  • CURO also intends to file recognition proceedings in Canada under Part IV of the Companies’ Creditors Arrangement Act.
  • CURO branches are open, operating as usual and continuing to serve customers in the U.S. and Canada.
  • (“Oaktree”), Caspian Capital LP, and Empyrean Capital Partners (the “Ad Hoc Group”) led negotiation of the RSA on behalf of creditors.
  • The DIP financing, which is subject to court approval, is expected to support the Company’s ongoing operations during the court-supervised process.

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Retrieved on: 
Thursday, March 21, 2024
Food, Beverage, Retail, Common stock, Form, Sale, BROS, Security (finance), Prospectus, Morgan Stanley, Form S-3, File, TSG Consumer Partners, 2nd Floor

Dutch Bros Inc. (NYSE: BROS; “Dutch Bros” or the “Company”) today announced commencement of a registered underwritten public offering of its Class A common stock, par value $0.00001 per share (the “Common Stock”), by certain selling stockholders associated with TSG Consumer Partners, L.P. (the “Selling Stockholders”).

Key Points: 
  • Dutch Bros Inc. (NYSE: BROS; “Dutch Bros” or the “Company”) today announced commencement of a registered underwritten public offering of its Class A common stock, par value $0.00001 per share (the “Common Stock”), by certain selling stockholders associated with TSG Consumer Partners, L.P. (the “Selling Stockholders”).
  • The Selling Stockholders also intend to grant the underwriter a 30-day option to purchase up to an additional 1,200,000 shares of Common Stock.
  • Dutch Bros is not offering any shares of Common Stock in this offering and will not receive any proceeds from the sale of shares of Common Stock by the Selling Stockholders but will bear a portion of the costs associated with the sale of such shares, other than any underwriting discounts and commissions.
  • A shelf registration statement on Form S-3 relating to Dutch Bros’ securities, including the Common Stock, has been filed with the SEC and became effective upon such filing.

Dutch Bros Inc. Announces Pricing of Secondary Public Offering of Class A Common Stock

Retrieved on: 
Thursday, March 21, 2024
Retail, Professional Services, Food, Beverage, Finance, Common stock, Form, Sale, BROS, Prospectus, Morgan Stanley, Form S-3, File, TSG Consumer Partners, 2nd Floor, Security (finance)

Dutch Bros Inc. (NYSE: BROS; “Dutch Bros” or the “Company”) today announced pricing of the previously announced registered underwritten public offering by certain selling stockholders associated with TSG Consumer Partners, L.P. (the “Selling Stockholders”) of 8,000,000 shares of Dutch Bros’ Class A common stock, par value $0.00001 per share (the “Common Stock”) at a public offering price of $34.00 per share.

Key Points: 
  • Dutch Bros Inc. (NYSE: BROS; “Dutch Bros” or the “Company”) today announced pricing of the previously announced registered underwritten public offering by certain selling stockholders associated with TSG Consumer Partners, L.P. (the “Selling Stockholders”) of 8,000,000 shares of Dutch Bros’ Class A common stock, par value $0.00001 per share (the “Common Stock”) at a public offering price of $34.00 per share.
  • The Selling Stockholders granted the underwriters a 30-day option to purchase up to an additional 1,200,000 shares of Common Stock.
  • Dutch Bros is not offering any shares of Common Stock in this offering and will not receive any proceeds from the sale of shares of Common Stock by the Selling Stockholders but will bear a portion of the costs associated with the sale of such shares, other than any underwriting discounts and commissions.
  • A shelf registration statement on Form S-3 relating to Dutch Bros’ securities, including the Common Stock, has been filed with the SEC and became effective upon such filing.

Mitek Provides Update on the Filing of Its Fiscal 2023 Annual Report on Form 10-K

Retrieved on: 
Tuesday, March 19, 2024
Software, Technology, Data Management, Security, File, International, EDGAR, Annual report, Security (finance), Cryptocurrency

Mitek is working with both its financial reporting provider as well as the SEC to resolve the issue.

Key Points: 
  • Mitek is working with both its financial reporting provider as well as the SEC to resolve the issue.
  • Mitek understands that the SEC released changes to its EDGAR filing system on March 18, 2024, which may be impacting the filing.
  • In order to proceed with the earnings call, Mitek must first file a Form 8-K with the SEC for the purpose of furnishing such earnings release.
  • If Mitek is able to file the Form 8-K successfully after the close of the market, then the earnings call will proceed.

Luna Innovations Alert: Class Action Investigation Following Delayed Release of Financial Information, Contact Johnson Fistel, LLP

Retrieved on: 
Friday, March 15, 2024
Class Action Lawsuit, Professional Services, Legal, Committee, File, News, LLP, Cryptocurrency

The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.

Key Points: 
  • The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.
  • If you bought securities and suffered significant losses on your investment, join our investigation now:
    Or for more information, contact Jim Baker at [email protected] or (619) 814-4471.
  • On March 12, 2024, Luna announced it will delay the release of its fourth quarter and fiscal year 2023 financial results.
  • Following the delayed filing news, Luna stock closed 35.78% lower on March 13, 2024.

CrowdStrike SEC Readiness Offering Prepares Public Companies for New Breach Disclosure Rules

Retrieved on: 
Thursday, March 14, 2024
Technology, Mobile, Wireless, Communications, Other Professional Services, Fintech, Legal, Insurance, IOT (Internet of Things), Finance, Consulting, Banking, Accounting, Social Media, Electronic Commerce, Professional Services, Security, Apps, Applications, Software, Networks, Internet, Hardware, Business, Data Management, Failure, Organization, Pressure, Face, XDR, Risk, Materiality, Blog, AI, Disclosure, File, Risk management

CrowdStrike (NASDAQ: CRWD) today unveiled CrowdStrike SEC Readiness Services , providing public companies the technology and expertise required to mitigate risk and comply with the new SEC breach disclosure rules.

Key Points: 
  • CrowdStrike (NASDAQ: CRWD) today unveiled CrowdStrike SEC Readiness Services , providing public companies the technology and expertise required to mitigate risk and comply with the new SEC breach disclosure rules.
  • These new regulations increase pressure on public companies and their boards, as determining the materiality of a breach can be difficult, and failure to comply with the requirements could result in litigation or financial penalties.
  • “The new SEC rules substantiate the gravity of today’s cybersecurity threats and have changed the way company boards should view cyber risk.
  • Materiality Tabletop Exercises: CrowdStrike experts design exercises that enable public companies to test their processes for determining if a security incident is material and requires filing an 8-K with the SEC.

Kinetik Announces Pricing of Secondary Offering of Common Stock

Retrieved on: 
Thursday, March 14, 2024
Energy, Other Energy, Oil, Gas, Citigroup, BofA Securities, Mizuho Securities, TD Securities, 3rd Floor, J. P. Morgan, APA Corporation, Offering, Goldman Sachs, KNTK, Telephone, Sale, News, Scotiabank, Prospectus, Morgan Stanley, Broadridge Financial Solutions, File, HSBC, MUFG, ATTN:, RBC Capital Markets, Security (finance)

Kinetik Holdings Inc. (NYSE: KNTK) (“Kinetik” or the “Company”) announced today the pricing of an underwritten secondary offering of 11,373,801 shares of its Class A common stock (the “Offering”) by Apache Midstream LLC (the “Selling Stockholder”), a subsidiary of Apache Corporation, at a price of $33.75 per share.

Key Points: 
  • Kinetik Holdings Inc. (NYSE: KNTK) (“Kinetik” or the “Company”) announced today the pricing of an underwritten secondary offering of 11,373,801 shares of its Class A common stock (the “Offering”) by Apache Midstream LLC (the “Selling Stockholder”), a subsidiary of Apache Corporation, at a price of $33.75 per share.
  • Kinetik is not selling any shares of Class A common stock in the Offering and will not receive the proceeds from any sale of shares by the Selling Stockholder.
  • The Selling Stockholder has granted to the underwriters a 30-day option to purchase up to an additional 1,706,070 shares of Kinetik’s Class A common stock.
  • In connection with the Offering, the Company’s Chief Executive Officer has agreed to purchase an aggregate of 14,814 shares of Class A common stock from the underwriters at the public offering price.

U.S. Food and Drug Administration (FDA) Has Accepted the New Drug Application (NDA) for Ensartinib

Retrieved on: 
Wednesday, March 13, 2024
Oncology, FDA, Health, Clinical Trials, Pharmaceutical, Biotechnology, Brain, NSCLC, New Drug Application, Patient, JAMA Oncology, NDA, Anaplastic lymphoma kinase, Crizotinib, Safety, File, Holding, Food, ALK, PDUFA, Pharmaceutical industry

Xcovery Holdings, Inc. , an oncology focused pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for ensartinib, an Anaplastic Lymphoma Kinase (ALK) inhibitor for the treatment of adult patients with metastatic ALK-positive non-small cell lung cancer (NSCLC).

Key Points: 
  • Xcovery Holdings, Inc. , an oncology focused pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for ensartinib, an Anaplastic Lymphoma Kinase (ALK) inhibitor for the treatment of adult patients with metastatic ALK-positive non-small cell lung cancer (NSCLC).
  • The filing is based on the results of the eXalt3, a randomized global phase III study designed to evaluate the efficacy and safety of ensartinib vs crizotinib in the first-line treatment of ALK-positive NSCLC.
  • The FDA granted the application Standard Review and assigned a Prescription Drug User Fee Act (PDUFA) goal date of December 28, 2024.
  • In the clinical trials, the drug has demonstrated robust and durable responses in ALK-positive NSCLC patients (both systemically and in the brain), with an extensively studied and well manageable safety profile.

Kinetik Announces Secondary Offering of Common Stock

Retrieved on: 
Wednesday, March 13, 2024
Energy, Other Energy, Oil, Gas, BofA Securities, Mizuho Securities, 3rd Floor, J. P. Morgan, APA Corporation, Offering, Goldman Sachs, KNTK, Telephone, Sale, News, Broadridge Financial Solutions, File, ATTN:, Security (finance)

Kinetik Holdings Inc. (NYSE: KNTK) (“Kinetik” or the “Company”) announced today the commencement of an underwritten secondary offering of 11,373,801 shares of its Class A common stock (the “Offering”) by Apache Midstream LLC (the “Selling Stockholder”), a subsidiary of Apache Corporation.

Key Points: 
  • Kinetik Holdings Inc. (NYSE: KNTK) (“Kinetik” or the “Company”) announced today the commencement of an underwritten secondary offering of 11,373,801 shares of its Class A common stock (the “Offering”) by Apache Midstream LLC (the “Selling Stockholder”), a subsidiary of Apache Corporation.
  • Kinetik is not selling any shares of Class A common stock in the Offering and will not receive the proceeds from any sale of shares by the Selling Stockholder.
  • In connection with the Offering, the Selling Stockholder intends to grant to the underwriters a 30-day option to purchase up to an additional 1,706,070 shares of Kinetik’s Class A common stock.
  • In connection with the Offering, the Company’s Chief Executive Officer has provided an indication of interest in purchasing shares of Class A common stock from the underwriters at the public offering price.

Ichor Holdings, Ltd. Announces Pricing of $125 Million Public Offering

Retrieved on: 
Thursday, March 14, 2024
Semiconductor, Engineering, Chemicals, Plastics, Technology, Manufacturing, Hardware, Montgomery Street, Needham & Company, Form, Telephone, Sale, Public expenditure, Attention, Security (finance), Lexington Avenue, Prospectus, Suite, File, ICHR

In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 500,000 of its ordinary shares at the public offering price, less underwriting commissions.

Key Points: 
  • In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 500,000 of its ordinary shares at the public offering price, less underwriting commissions.
  • The offering is expected to close on March 18, 2024, subject to the satisfaction of customary closing conditions.
  • TD Cowen and Stifel are acting as joint book-running managers and representatives of the underwriters for the offering.
  • The final terms of the offering will be disclosed in a final prospectus supplement to be filed with the SEC.